Teenager Stows Away in Airplane Wheel Well
Teenager Stows Away in Airplane Wheel Well
Wu-Tang Clan Affiliate Attempts Suicide by Cutting off Penis, Jumping from Balcony
Wu-Tang Clan Affiliate Attempts Suicide by Cutting off Penis, Jumping ...
Proposed 2015 Budget Would Increase Taxes by $1.4 Trillion over the Next Decade
Proposed 2015 Budget Would Increase Taxes by $1.4 Trillion over the Ne...
Woman Blogs About First Year of Marriage; Sitcom Deal in the Works
Woman Blogs About First Year of Marriage; Sitcom Deal in the Works
Job Listings

Healthpoint Ltd to Pay $1 Mln to Massachusetts to Settle Marketing of Xenoderm Matter

On Friday, Massachusetts Attorney General Martha Coakley said Massachusetts had reached a settlement with Healthpoint and its general partner DFB Pharmaceuticals Inc as part of a broader national settlement of $48 million.

 

The settlement was to resolve allegations of wrongfully charging Medicaid and Medicare for the Xenaderm ointment though it was not approved by the FDA. According to Coakley, Massachusetts would be receiving $996,000. She said in a statement, “This settlement demonstrates the importance of policing the pharmaceutical industry and remaining vigilant with respect to drug marketing misconduct.”

 

However, the Texas-based Healthpoint has not admitted to any wrongdoing.



Get JD Journal in Your Mail
Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!


 

The national-level settlement had been announced by the DOJ in December last year, over the complaint it had filed under the False Claims Act in 2011. The complaint had filed against Healthpoint in the District of Masschusetts.

 

According to the complaint by the U.S. Justice Department, Healthpoint had submitted false statements about Xenaderm to get Medicaid and Medicare money. The active ingredient in Xenaderm was found ineffective by the FDA back in the 70s, and prosecutors alleged that Healthpoint had acted with full knowledge that the ingredient, trypsin, was not approved by FDA.

 

In December, 2012, Healthpoint agreed to a settlement of up to $33 million with 47 states and $15 million for payment to the Medicare prescription drug benefit program.

 

Healthpoint is by no means alone in such practices. A number of companies, starting with Eon Labs in 2010, have been cornered by the DOJ over false claims. Eon paid $3.5 million to resolve things. In October 2012, the FDA issued an order prohibiting more than four thousand online pharmacies from selling FDA unapproved drugs.

 

Xenoderm was marketed for the treatment of bed sores and other sores caused by pressure.

Did you like this? Share it:
Healthpoint Ltd to Pay $1 Mln to Massachusetts to Settle Marketing of Xenoderm Matter by

Tagged: , ,

Posted by on February 25, 2013. Filed under Breaking News,Health. You can follow any responses to this entry through the RSS 2.0. You can skip to the end and leave a response. Pinging is currently not allowed.